Quadrivalent Global Market Report 2024

Description

“Quadrivalent Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on quadrivalent market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for quadrivalent? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The quadrivalent market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

1) By Type: Intradermal Shot; Intramuscular Injection; Nasal Spray
2) By Technology: Conjugated; Live; Inactivated; Recombinant; Toxoid; Other Technologies
3) By Disease: Cancer; Hepatitis; Pneumococcal disease; COVID-19; Influenza; Human Papilloma Virus; Meningococcal Disease; Polio; Rotavirus; Other Diseases
4) By Age Group: Pediatric; Adult
5) By Distribution Channel: Hospital And Pharmacy; Government Suppliers; Other Channels (NGOs)
Companies Mentioned: AstraZeneca Plc; Serum Institute of India Private Limited; Sanofi S.A.; GlaxoSmithKline Plc; CSL Limited
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

A quadrivalent vaccine stimulates the immune system to respond to distinct antigens, typically targeting four different viruses or bacteria. In the context of influenza, a quadrivalent vaccine is designed to provide protection against four specific flu viruses, including two type A and two type B viruses.

The primary types of quadrivalent vaccines include intradermal shots, intramuscular injections, and nasal sprays. An intradermal shot involves injecting the vaccine between the epidermis and hypodermis, the top and bottom layers of the skin, as defined by the Center for Disease Control (CDC). These vaccines are formulated using various technologies, including conjugated, live, inactivated, recombinant, toxoid, and others, aiming to immunize against a range of diseases such as cancer, hepatitis, pneumococcal disease, COVID-19, influenza, human papillomavirus, meningococcal disease, polio, rotavirus, and others affecting both pediatric and adult age groups. Distribution channels for these vaccines include hospitals, pharmacies, government suppliers, and other outlets.

The quadrivalent market research report is one of a series of new reports from The Business Research Company that provides quadrivalent market statistics, including quadrivalent industry global market size, regional shares, competitors with a quadrivalent market share, detailed quadrivalent market segments, market trends and opportunities, and any further data you may need to thrive in the quadrivalent industry. This quadrivalent market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The quadrivalent market size has grown strongly in recent years. It will grow from $8.28 billion in 2023 to $8.98 billion in 2024 at a compound annual growth rate (CAGR) of 8.4%. The growth observed in the historical period can be attributed to factors such as the complexity of diseases, educational initiatives, past health events, overall expansion in healthcare, and technological progress.

The quadrivalent market size is expected to see strong growth in the next few years. It will grow to $12.88 billion in 2028 at a compound annual growth rate (CAGR) of 9.4%. The anticipated growth in the forecast period can be attributed to factors such as global health events, competitive dynamics, educational campaigns, regulatory changes, and the evolving patterns of diseases. Key trends expected in the forecast period include disease prevalence, the regulatory environment, healthcare infrastructure, consumer awareness and education, and the competitive landscape.

The anticipated rise in the prevalence of chronic and infectious diseases is set to drive the growth of the quadrivalent market. Chronic diseases, attributed to genetics and lifestyle, and infectious diseases caused by agents such as viruses, bacteria, fungi, or protozoa, pose significant health challenges. Quadrivalent vaccines play a crucial role in preventing morbidity and mortality from serious infections, addressing diseases beyond their targeted infections. These vaccines are increasingly employed in preventing chronic diseases associated with infectious agents involved in carcinogenesis. According to the World Health Organization (WHO), 17 million people succumb to chronic or noncommunicable diseases (NCDs) annually, and in 2021, there were an estimated 247 million cases of malaria globally, resulting in approximately 619,000 fatalities. Thus, the escalating prevalence of chronic and infectious diseases is a driving force behind the quadrivalent market's growth.

The expected growth in the quadrivalent market is also fueled by the global expansion of immunization coverage. Immunization coverage, indicating the proportion of a population receiving specific vaccines within a defined period, drives increased demand for vaccines. Quadrivalent vaccines, protecting against four strains, are often integrated into routine vaccination programs to combat multiple disease threats in a single shot. The World Health Organization reported an improvement in the number of zero-dose children, decreasing from 18.1 million in 2021 to 14.3 million in 2022. Moreover, global coverage for the initial dose of the human papillomavirus (HPV) vaccine in girls increased from 16% in 2021 to 21% in 2022. Thus, the rising global immunization coverage is expected to propel the quadrivalent market forward.

A key trend gaining prominence in the quadrivalent market is product innovation. Major companies in the sector are actively developing innovative solutions to reinforce their market positions. AstraZeneca, a UK-based pharmaceutical company, launched FluMist quadrivalent (Influenza Vaccination Live, Intranasal) in September 2022. This FDA-approved nasal-spray flu vaccine for individuals aged 2 to 49 is administered through a needle-free nasal spray. It is available in trivalent or quadrivalent formulations, providing a live attenuated influenza vaccine (LAIV) covered by most health insurance plans and the vaccines for children program.

Major companies in the quadrivalent market are strategically introducing innovative products such as Narcan to drive market revenues. Narcan (naloxone hydrochloride) nasal spray 4 mg is designed to reverse opioid overdoses during a surge in overdose deaths. Sandoz International GmbH, a Germany-based pharmaceutical company, launched Narcan in December 2021. This nasal spray quickly blocks the effects of opioids on the brain, restoring normal breathing and consciousness in individuals experiencing an overdose. It is specifically designed to rapidly reverse the life-threatening effects of an opioid overdose.

In February 2023, China-based biotechnology company Clover Biopharmaceuticals Ltd. entered into a partnership with Adimmune Corporation, a Taiwan-based biopharmaceutical company. This collaboration leverages Adimmune's manufacturing and distribution expertise in providing essential vaccines to Asian populations. Clover aims to strengthen its position as a premier respiratory vaccine franchise and enhance synergies with ongoing COVID-19 vaccine commercialization. As part of this collaboration, Clover will distribute Adimmune's AdimFlu-S (QIS), the only imported quadrivalent influenza vaccination authorized in mainland China, utilizing its established commercial infrastructure.

Major companies operating in the quadrivalent market report are AstraZeneca Plc, Serum Institute of India Private Limited, Sanofi S.A., GlaxoSmithKline Plc, CSL Limited, Bharat Biotech International Limited, Hualan Biological Engineering Inc., Merck & Co. Inc., Johnson & Johnson Services Inc., Novartis AG, Pfizer Inc., Xenetic Biosciences Inc., Bio Med Pvt. Ltd., Walvax Biotechnology Co. Ltd., Chongqing Zhifei Biological Products Co. Ltd., Hoffmann-La Roche Ltd., Gamma Vaccines Pty Ltd., Biodiem Ltd., Emergent BioSolutions Inc., Biological E. Limited, GSK Biologicals SA, Institute of Vaccines and Biological Products Chinese Academy of Medical Sciences, Wuhan Institute of Biological Products Co. Ltd., Beijing Tian Tan Biological Products Co. Ltd., Shanghai Zhijiang Bio-pharm Co. Ltd., MedImmune, Bio Farma, Butantan Institute, Pasteur Institute of India, China National Biotec Group Co. Ltd. (CNBG) .

North America was the largest region in the quadrivalent market in 2023. The regions covered in the quadrivalent market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the quadrivalent market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The quadrivalent market consists of sales of afluria quadrivalent, fluarix quadrivalent, flublok quadrivalent, fluzone quadrivalent (influenza virus vaccine), flulaval quadrivalent, flucelvax quadrivalent, menactra and menveo. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Product Code: r11280

1. Executive Summary

2. Quadrivalent Market Characteristics

3. Quadrivalent Market Trends And Strategies

4. Quadrivalent Market - Macro Economic Scenario

4.1. Impact Of High Inflation On the Market
4.2. Ukraine-Russia War Impact On the Market
4.3. COVID-19 Impact On the Market

5. Global Quadrivalent Market Size and Growth

5.1. Global Quadrivalent Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Quadrivalent Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Quadrivalent Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Quadrivalent Market Segmentation

6.1. Global Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Intradermal Shot
Intramuscular Injection
Nasal Spray
6.2. Global Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Conjugated
Live
Inactivated
Recombinant
Toxoid
Other Technologies
6.3. Global Quadrivalent Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Cancer
Hepatitis
Pneumococcal disease
COVID-19
Influenza
Human Papilloma Virus
Meningococcal Disease
Polio
Rotavirus
Other Diseases
6.4. Global Quadrivalent Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Pediatric
Adult
6.5. Global Quadrivalent Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospital And Pharmacy
Government Suppliers
Other Channels (NGOs)

7. Quadrivalent Market Regional And Country Analysis

7.1. Global Quadrivalent Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Quadrivalent Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Quadrivalent Market

8.1. Asia-Pacific Quadrivalent Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Quadrivalent Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Quadrivalent Market

9.1. China Quadrivalent Market Overview
9.2. China Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Quadrivalent Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Quadrivalent Market

10.1. India Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Quadrivalent Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Quadrivalent Market

11.1. Japan Quadrivalent Market Overview
11.2. Japan Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Quadrivalent Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Quadrivalent Market

12.1. Australia Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Quadrivalent Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Quadrivalent Market

13.1. Indonesia Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Quadrivalent Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Quadrivalent Market

14.1. South Korea Quadrivalent Market Overview
14.2. South Korea Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Quadrivalent Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Quadrivalent Market

15.1. Western Europe Quadrivalent Market Overview
15.2. Western Europe Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Quadrivalent Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Quadrivalent Market

16.1. UK Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Quadrivalent Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Quadrivalent Market

17.1. Germany Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Quadrivalent Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Quadrivalent Market

18.1. France Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Quadrivalent Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Quadrivalent Market

19.1. Italy Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Quadrivalent Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Quadrivalent Market

20.1. Spain Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Quadrivalent Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Quadrivalent Market

21.1. Eastern Europe Quadrivalent Market Overview
21.2. Eastern Europe Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Quadrivalent Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Quadrivalent Market

22.1. Russia Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Quadrivalent Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Quadrivalent Market

23.1. North America Quadrivalent Market Overview
23.2. North America Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Quadrivalent Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Quadrivalent Market

24.1. USA Quadrivalent Market Overview
24.2. USA Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Quadrivalent Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Quadrivalent Market

25.1. Canada Quadrivalent Market Overview
25.2. Canada Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Quadrivalent Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Quadrivalent Market

26.1. South America Quadrivalent Market Overview
26.2. South America Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Quadrivalent Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Quadrivalent Market

27.1. Brazil Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Quadrivalent Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Quadrivalent Market

28.1. Middle East Quadrivalent Market Overview
28.2. Middle East Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Quadrivalent Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Quadrivalent Market

29.1. Africa Quadrivalent Market Overview
29.2. Africa Quadrivalent Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Quadrivalent Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Quadrivalent Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Quadrivalent Market Competitive Landscape And Company Profiles

30.1. Quadrivalent Market Competitive Landscape
30.2. Quadrivalent Market Company Profiles
- 30.2.1. AstraZeneca Plc
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Serum Institute of India Private Limited
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Sanofi S.A.
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. GlaxoSmithKline Plc
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. CSL Limited
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Global Quadrivalent Market Competitive Benchmarking

32. Global Quadrivalent Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Quadrivalent Market

34. Quadrivalent Market Future Outlook and Potential Analysis

34.1 Quadrivalent Market In 2028 - Countries Offering Most New Opportunities
34.2 Quadrivalent Market In 2028 - Segments Offering Most New Opportunities
34.3 Quadrivalent Market In 2028 - Growth Strategies
- 34.3.1 Market Trend Based Strategies
- 34.3.2 Competitor Strategies

35. Appendix

35.1. Abbreviations
35.2. Currencies
35.3. Historic And Forecast Inflation Rates
35.4. Research Inquiries
35.5. The Business Research Company
35.6. Copyright And Disclaimer